The National Pharmaceutical Pricing Authority (NPPA) issued an addendum on 29 August 2025 to its earlier orders on ceiling price fixation of IV fluids (non-glass with special features). Three manufacturers: M/s BML Parenteral Drugs, M/s Hindustan Polyfab, and M/s Pharma Implex Laboratories Pvt. Ltd. were added in Table B. Specific formulations from Table A were assigned to each, bringing them under the regulated pricing framework.
The National Pharmaceutical Pricing Authority (NPPA) under the Ministry of Chemicals and Fertilizers released an addendum to its earlier orders dated 27 March 2025 and 4 July 2025, concerning ceiling price fixation of IV fluid formulations (non-glass with special features).
Key points include:
- The addendum introduces three new manufacturers to Table B: M/s BML Parenteral Drugs (Euro Head Cap), M/s Hindustan Polyfab (Euro Head/LDPE Bottles), and M/s Pharma Implex Laboratories Pvt. Ltd. (Euro Cap/Head Bottles).
- Clauses (h2), (h3), and (h4) specify that for each manufacturer, only select formulations from Table A will be covered under ceiling prices, ensuring regulated pricing compliance.
This update expands the scope of NPPA’s pricing regulation for IV fluid packs.